Manufacturer profile
EIPICO
Every published regulatory action recorded against this manufacturer, across all African authorities Drug Eye Africa monitors. Built strictly from published regulatory decisions and nothing else.
What these numbers are. They are counts of published regulatory actions recorded on this register. They are not a finding about the company, not an allegation, and not a measure of product quality. A manufacturer appearing here has had actions published against named products by named authorities; the actions speak for themselves and each one links to its primary notice.
8
Recorded actions
1
Countries
1
Authorities
0
Class I actions recorded
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-EG-2026-0071 | Jul 2026 | EG | Flumox 1000 Film coated tablet EIPICO | 2511915 · 2600425 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0052 | Jun 2026 | EG | Dexatrolophthalmic & otic suspension EIPICO | 2501758 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0039 | May 2026 | EG | Flumox1000mg film coated tablet EIPICO | 2410995 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2026-0015 | Mar 2026 | EG | E-moxclav1gm film coated tablet Eipico | 2503745 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2025-0099 | Dec 2025 | EG | Selgon 10 mg Rectal Suppositories for children Eipico | 2504921 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2025-0094 | Dec 2025 | EG | Epifasi 5000 IU ampoule Eipico | 2505156 · 250338 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2025-0013 | Apr 2025 | EG | Flumox 1000 mg fct ايبيكو | 2400905 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-EG-2024-0057 | Dec 2024 | EG | Epizithro 200 mg/5ml EIPICO | 2306705 | Recall | Unclassified | Tier 1 · Regulator-published |
Counts are of published regulatory actions recorded on this register. They are not a finding about the company, and this page says so.
Names as published
This profile groups 3 spellings used by the issuing authorities: EIPICO; Eipico; ايبيكو.
Company response
Drug Eye Africa has not yet invited a response from this company. That is our omission and not the company’s silence, and it is recorded here as one.
How this page is built
- Published regulator decisions only — no press reports, no allegations
- Name matching is conservative: only corporate-form suffixes are stripped, and a name that would reduce to a single token is kept whole
- Every action links to its primary notice